Literature DB >> 6022980

Primary retroperitoneal tumors.

J W Braasch, A B Mon.   

Abstract

Entities:  

Mesh:

Year:  1967        PMID: 6022980     DOI: 10.1016/s0039-6109(16)38243-3

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


× No keyword cloud information.
  19 in total

1.  Giant pre-sacral neurofibroma.

Authors:  M Agarwal; A Azzopardi; G R Mufti
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

2.  [Retroperitoneal leiomyosarcoma. A rare differential diagnosis of an adrenal tumor].

Authors:  J Hodzic; K Golka; K Möhring; G Riedasch
Journal:  Urologe A       Date:  2006-02       Impact factor: 0.639

3.  Teratomas in children.

Authors:  J B Rau; C C Murthi
Journal:  Indian J Pediatr       Date:  1975-08       Impact factor: 1.967

Review 4.  Primary Epithelial Neuroendocrine Tumors of the Retroperitoneum.

Authors:  Ahmed Dehal; Sean Kim; Aamna Ali; Thomas Walbolt
Journal:  Perm J       Date:  2015

5.  Benign retroperitoneal teratoma.

Authors:  V H Talib; A Zaheer; N S Talib; Z Sultana; S D Patil
Journal:  Indian J Pediatr       Date:  1974-02       Impact factor: 1.967

6.  [Proceedings: Retroperitoneal tumors: pathology (author's transl)].

Authors:  G Pliess
Journal:  Langenbecks Arch Chir       Date:  1973

7.  [Proceedings: Clinical symptomatology and differential diagnosis of retroperitoneal tumors (author's transl)].

Authors:  H Remé
Journal:  Langenbecks Arch Chir       Date:  1973

8.  Unilateral lumbar sympathectomy due to retroperitoneal tumour.

Authors:  R C Brown; D N Maisey; J L Day
Journal:  Br Med J       Date:  1978-02-18

9.  Improved survival following complete excision of retroperitoneal sarcomas.

Authors:  P C McGrath; J P Neifeld; W Lawrence; R M DeMay; S Kay; J S Horsley; G A Parker
Journal:  Ann Surg       Date:  1984-08       Impact factor: 12.969

10.  Resectability and survival in retroperitoneal sarcomas.

Authors:  C P Karakousis; A F Velez; R Gerstenbluth; D L Driscoll
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.